Funder
Danmarks Grundforskningsfond
Reference55 articles.
1. A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats;Andreassen;Am. J. Physiol. Endocrinol. Metab.,2014
2. KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats;Andreassen;Mol. Metabol.,2021
3. Glucagon-like peptide-1 analogues in nonalcoholic steatohepatitis: from bench to bedside;Armstrong;Clin. Liver Dis.,2017
4. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis;Armstrong;J. Hepatol.,2016
5. Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study;Aronne;J. Clin. Endocrinol. Metab.,2007
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献